Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2026

May 12, 2026

60507_rns_2026-05-12_29531dae-093b-4838-bad6-811ab464bbfa.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Pfizer

Pfizer Limited

The Capital, 1802/1901,
Plot No. C - 70, G Block, Bandra Kurla Complex,
Bandra (East), Mumbai 400 051.
Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

May 12, 2026

The Corporate Relationship Dept.
BSE Limited
1st Floor, P.J.Towers
Dalal Street, Fort
Mumbai – 400 001
Scrip Code: 500680

The Manager, Listing Dept.
The National Stock Exchange of India Ltd.
Exchange Plaza, 5th Floor, Plot No. C/1,
G Block Bandra-Kurla Complex, Bandra (E)
Mumbai – 400 051
Scrip Symbol: PFIZER

Dear Sirs / Madam,

Sub: Intimation of date of Annual General Meeting.

Ref: Regulation 30 of the Securities and Exchange Board India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors, at their meeting held on May 12, 2026, approved convening of the 75th Annual General Meeting of the Company on Tuesday, July 28, 2026, through Video-Conferencing ("VC") / Other Audio-Visual Means ("OAVM") in accordance with the relevant Circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India.

We request you to please take the above on record.

Thanking you,

Yours truly,
For Pfizer Limited

Prajyeeet Nair
Digitally signed by
Prajyeeet Nair
Date: 2026.05.12
20:11:38 +05'30'

Prajyeeet Nair
Director – Corporate Services & Company Secretary

CIN: L24231MH1950PLC008311
Email ID: [email protected]
Website: www.pfizerltd.co.in